(Q33709238)

28 July 2017

1 reference

title

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy (English)

1 reference

28 July 2017

1 reference

De Vries P

1

1 reference

28 July 2017

Villalón CM

series ordinal

2

1 reference

28 July 2017

Saxena PR

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

European Journal of Pharmacology

28 July 2017

1 reference

28 July 2017

375

1 reference

28 July 2017

61-74

1 reference

28 July 2017

1-3

1 reference

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Differences in ligand binding profiles between cloned rabbit and human 5-HT1D alpha and 5-HT1D beta receptors: ketanserin and methiothepin distinguish rabbit 5-HT1D receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

5-HT receptors mediating contractions of the isolated human coronary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The influence of the trigeminal ganglion on carotid blood flow in anaesthetized guinea-pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Pharmacological characterisation of a cloned dog 5-HT1B receptor cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Identification and characterization of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)- 3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Naratriptan: biological profile in animal models relevant to migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

5-HT1B receptors mediate potent contractile responses to 5-HT in rat caudal artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Rizatriptan has central antinociceptive effects against durally evoked responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Blockade of porcine carotid vascular response to sumatriptan by GR 127935, a selective 5-HT1D receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Nature of 5-HT1-like receptors mediating depressor responses in vagosympathectomized rats; close resemblance to the cloned 5-ht7 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomoses; involvement of 5-HT1B/1D and novel receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The 5-HT7 receptor: orphan found

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The modulation of the increase in rat facial skin blood flow observed after trigeminal ganglion stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Trigeminal ganglion stimulation increases facial skin blood flow in the rat: a major role for calcitonin gene-related peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Clinical and experimental effects of sumatriptan in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor func

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Inhibition of calcitonin gene-related peptide by h-CGRP(8-37) antagonizes the cerebral dilator response from nasociliary nerve stimulation in the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Current concepts of the pathophysiology of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Serotonin 5-HT1B/1D Receptor Agonists in Migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Extracranial vasodilation mediated by vasoactive intestinal polypeptide (VIP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Stimulation of the trigeminal ganglion increases flow in the extracerebral but not the cerebral circulation of the monkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Stimulation of an intracranial trigeminally-innervated structure selectively increases cerebral blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Stimulation of 5-HT1B receptors causes hypothermia in the guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Mode of action of the anti-migraine drug sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The mode of action of sumatriptan is vascular? A debate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Single dose pharmacokinetics of sumatriptan in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Effect of antimigraine drugs on dural blood flows and resistances and the responses to trigeminal stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Decreased carotid arterial resistance in cats in response to trigeminal stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Responses of the dural circulation to electrical stimulation of the trigeminal ganglion in the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Pathophysiology of the migraine aura. The spreading depression theory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Prevalence and impact of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Coronary side-effect potential of current and prospective antimigraine drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Trigeminal ganglion elicited increases in nucleus trigeminal caudalis blood flow: a novel migraine model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Nitric oxide is a key molecule in migraine and other vascular headaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Investigation of the role of tachykinin NK1, NK2 receptors and CGRP receptors in neurogenic plasma protein extravasation in dura mater

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Recent advances in mechanisms of spreading depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea-pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The effects of antimigraine drugs on the vascular responses by-5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

5-HT1-like receptor agonists and the pathophysiology of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

5-HT1-like receptors: a time to bid goodbye.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

GR127935: a potent and selective 5-HT1D receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Simultaneous measurement of plasma protein extravasation and carotid vascular resistance in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

GR127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Expression of serotonin receptor mRNAs in blood vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Assessment of peripheral vascular effects of antimigraine drugs in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Inhibition of nitric oxide biosynthesis and carotid arteriovenous anastomotic shunting in the pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The effect of nitric oxide donors on haemodynamics and blood flow distribution in the porcine carotid circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Mediation of 5-HT-induced external carotid vasodilatation in GR 127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Brain stem activation in spontaneous human migraine attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Ketanserin and ritanserin discriminate between recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900197-1

10.1016/S0014-2999(99)00197-1

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference